Journal of Thyroid Disorders & Therapy
Open Access
ISSN: 2167-7948
+44 1300 500008
ISSN: 2167-7948
+44 1300 500008
Vladimir Avramoski
Macedonia
Dr. Vladimir Avramoski is a distinguished gastroenterologist and hepatologist at the University Clinic of Gastroenterology and Hepatology in Skopje, Macedonia. He completed his medical training at one of Macedonia's leading medical universities and further specialized in gastroenterology and hepatology, focusing on the diagnosis, treatment, and management of gastrointestinal and liver diseases. Dr. Avramoski’s expertise spans a wide range of conditions, including liver diseases such as hepatitis, cirrhosis, and liver cancer, as well as digestive disorders like inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastrointestinal cancers. He is dedicated to improving patient care through advanced diagnostic techniques, including endoscopy, imaging, and molecular diagnostics, as well as innovative treatment strategies. In addition to his clinical work, Dr. Avramoski is actively involved in academic research and the education of medical students and residents at the University Clinic. His contributions to clinical research have been instrumental in advancing the understanding of gastrointestinal and liver diseases, and he is particularly interested in finding new therapeutic approaches to improve patient outcomes. Through his clinical and research efforts, Dr. Avramoski continues to play a key role in advancing the field of gastroenterology and hepatology in Macedonia, improving the health and quality of life of his patients.
Case Report
Thyrotoxicosis Associated with Cholestatic Jaundice Treated with Therapeutic Plasma Exchange-Case Report
Author(s): Irfan Ahmeti, Viktorija Chalovska, Nevena Manevska, Pavlina Dzekova-Vidimliski, Vladimir Avramoski and Daniela Pop GjorcevaIrfan Ahmeti, Viktorija Chalovska, Nevena Manevska, Pavlina Dzekova-Vidimliski, Vladimir Avramoski and Daniela Pop Gjorceva
Thyroid disorders, especially thyrotoxicosis, are commonly associated with hepatic dysfunction, but cholestasis is rarely reported. Heart failure, infection, weight loss may play role in the pathogenesis of cholestasis. Cholestasis could be worsened by treatment of hyperthyroidism using Thiamazole, but cholestasis in undiagnosed thyrotoxicosis is uncommon. We present 23 year old female with jaundice, goiter, palpitation and confirmed thyrotoxicosis associated with hepatomegaly, hepatocelluar damage and cholestasis. Liver biopsy excluded the suspicion of autoimmune hepatitis. Therapeutic plasma exchange was performed 5 days after starting the treatment with thyroid supressive therapy, and hepatoprotective therapy due to progressive increase of serum levels of bilirubin (conjugated/direct) and liver enzymes. The patient treatment continued with low doses of thyroid suppressive the.. View More»
DOI:
10.4172/2167-7948.1000211